The increased expression of SRSF3 enhances gemcitabine resistance of pancreatic cancer cells both in vitro and in vivo, whereas silence of SRSF3 by siRNAs exhibits an opposite effect. The gene discussed is SRSF3; the disease is familial pancreatic carcinoma.